Hasta La Gadget!

Amazon is permanently offering free restaurant delivery via Grubhub+ as part of its Prime subscription, the company announced. If you live in the US and pay $139 per year for a Prime subscription, you’ll pay no fee for eligible GrubHub orders over $12. You’ll also see lower service fees, 5 percent credit back on pickup orders and exclusive offers. 

That works out to a value of $120 per year, according to Amazon. The retail giant had previously offered Prime clients a free one-year subscription to GrubHub+, but once it auto-renewed, you had to pay $129 per year on top of your Prime subscription. Now, it appears to be a permanent Prime inclusion.

Amazon’s US customers can access GrubHub on Amazon.com and in the Amazon Shopping app with an “identical” ordering experience and prices to Grubhub.com or Grubhub’s app, according to Amazon. To activate the offer, go to Amazon.com/grubhub. On top of the free delivery, Prime members can get $5 off GrubHub orders of $25 or more through June 2nd.

Though widely used, restaurant delivery services have been controversial. Both restaurants and customers complain about high delivery fees, and drivers are often receive low pay while shouldering heavy workloads. Most fees don’t go to the driver, so many customers feel the need to add a tip onto the already high fees. In Europe, a deal was recently struck to reclassify millions of food delivery app workers as employees. 

Amazon’s Prime membership includes other perks like Prime Video and free same-day delivery. However, it recently added an additional $3 per month fee to get Prime Video without ads (except for sporting events), and unlimited grocery delivery from Whole Foods or Amazon Fresh costs an additional $10 per month. 

This article originally appeared on Engadget at https://www.engadget.com/amazon-prime-customers-in-the-us-now-get-free-grubhub-delivery-075319082.html?src=rss

Sometimes, having to open a link from within another app on mobile could be disruptive and take you away from the task you were trying to accomplish. Now an update for Chrome could help keep you focused with the task at hand. When you click on a link within Gmail, for instance, and open a Chrome tab within the app, you can tap on the chevron icon in the toolbar right next to the “x” or the close button to minimize the browser. That turns the open tab into a compact, floating picture-in-picture window that you can drag anywhere on the screen. 

You can keep it minimized while you use the original app, and the moment you’re ready to look at its contents, you only have to tap the floating window to restore the tab to its original size. We were already able to use the new feature on Android within Gmail. You’ll also be able to take advantage of it soon if you don’t have it yet, as long as your default browser is Chrome and you keep it updated. The feature is even enabled by default, so you don’t have to do anything to switch it on. Of course, you can always send an in-app tab to the Chrome browser if keeping different tasks open in separate windows makes you more productive.

This article originally appeared on Engadget at https://www.engadget.com/google-makes-it-easier-to-multi-task-with-minimized-in-app-chrome-tabs-060209780.html?src=rss

Chinese scientists have achieved a significant medical milestone by successfully curing a long-term type 2 diabetes patient using a novel cell therapy. This breakthrough, reported on April 30 in the journal Cell Discovery, represents the world’s first successful use of stem cell-derived islet transplantation for diabetes.

The patient, a 59-year-old who had been managing diabetes for 25 years, received a transplant of pancreatic cells derived from his own stem cells in 2021 at Shanghai Changzheng Hospital. Prior to this, he had experienced a severe decline in pancreatic islet function following a kidney transplant in 2017, necessitating daily insulin injections.

The innovative treatment involved converting the patient’s blood cells into stem cells, which were then transformed into pancreatic islet cells. Within 11 weeks of the transplant, the patient no longer required external insulin, and within a year, he was able to discontinue oral diabetes medication altogether. Follow-up examinations indicated restored pancreatic and normal kidney functions, suggesting the patient had been cured of diabetes.

Diabetes remains a major global health challenge, affecting 422 million people worldwide, with current management primarily relying on insulin injections and other medications. This groundbreaking achievement in China, which comes after more than a decade of research, offers new hope for a potential cure.

Looking ahead, the FDA has approved a similar cell therapy developed by a Chicago-based startup for type 1 diabetes, showing a growing interest in this approach. However, Chinese researchers emphasize the need for further studies to confirm the long-term efficacy and broader applicability of their treatment. This pioneering work opens new avenues for diabetes therapy, potentially transforming the lives of millions affected by this chronic condition.

Scientists Cure Diabetes With Stem Cell Therapy In World First

, original content from Ubergizmo. Read our Copyrights and terms of use.

Chinese scientists have achieved a significant medical milestone by successfully curing a long-term type 2 diabetes patient using a novel cell therapy. This breakthrough, reported on April 30 in the journal Cell Discovery, represents the world’s first successful use of stem cell-derived islet transplantation for diabetes.

The patient, a 59-year-old who had been managing diabetes for 25 years, received a transplant of pancreatic cells derived from his own stem cells in 2021 at Shanghai Changzheng Hospital. Prior to this, he had experienced a severe decline in pancreatic islet function following a kidney transplant in 2017, necessitating daily insulin injections.

The innovative treatment involved converting the patient’s blood cells into stem cells, which were then transformed into pancreatic islet cells. Within 11 weeks of the transplant, the patient no longer required external insulin, and within a year, he was able to discontinue oral diabetes medication altogether. Follow-up examinations indicated restored pancreatic and normal kidney functions, suggesting the patient had been cured of diabetes.

Diabetes remains a major global health challenge, affecting 422 million people worldwide, with current management primarily relying on insulin injections and other medications. This groundbreaking achievement in China, which comes after more than a decade of research, offers new hope for a potential cure.

Looking ahead, the FDA has approved a similar cell therapy developed by a Chicago-based startup for type 1 diabetes, showing a growing interest in this approach. However, Chinese researchers emphasize the need for further studies to confirm the long-term efficacy and broader applicability of their treatment. This pioneering work opens new avenues for diabetes therapy, potentially transforming the lives of millions affected by this chronic condition.

Scientists Cure Diabetes With Stem Cell Therapy In World First

, original content from Ubergizmo. Read our Copyrights and terms of use.

Newly proposed Congressional legislation would require the US to conduct security reviews for connected vehicles built by automakers from China and “other countries of concern.” Rep. Elissa Slotkin (D-MI), a former CIA analyst and Pentagon official who has championed the issue, introduced the bill on Wednesday.

If passed by Congress (a tall order these days), the Connected Vehicle National Security Review Act would establish a formal review process for connected autos from Chinese companies. It would also allow the Department of Commerce to limit or ban these cars and other vehicles before they reach US consumers.

“Today’s vehicles are more sophisticated than ever, carrying cameras, radars and other sophisticated sensors, plus the ability to process, transmit and store the data they gather from the United States,” said Slotkin. “If allowed into our markets, Chinese connected vehicles offer the Chinese government a treasure trove of valuable intelligence on the United States, including the potential to collect information on our military bases, critical infrastructure like the power grid and traffic systems, and even locate specific U.S leaders should they so choose.”

Rep. Elissa Slotkin

In a speech on the House floor earlier this month, Slotkin noted that Chinese EVs, often sold much cheaper than their US and European counterparts, could quickly gain a significant share of the American market. She cited how Chinese vehicles, first sold in Europe in 2019, now make up almost a quarter of its market. The representative also recently pushed Secretary of the Army Christine Wormuth and Secretary of Defense Lloyd Austin on the security gap.

Alternatively (and perhaps ideally), legislators could pass a comprehensive data privacy law rather than dealing with these issues piecemeal.

The bill’s introduction follows the Biden Administration’s quadrupling of import tariffs on Chinese EVs. The White House’s new EV levies grew from 25 percent to 100 percent, following China’s EV exports rising 70 percent between 2022 and 2023.

In February, the White House also ordered the Department of Commerce to investigate the risks of connected vehicles from China and other adversaries. However, that action was conducted through an executive order and could be undone by future administrations. Slotkin’s legislation would close those loopholes if it makes it through Congress — rarely a safe bet in today’s highly obstructed and contentious political environment.

This article originally appeared on Engadget at https://www.engadget.com/us-house-bill-would-require-national-security-reviews-on-connected-vehicles-from-china-211505179.html?src=rss